Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132.

Cancer Sci · 2016 · PMC4968607 · PMID 26987571

Europe PMC DOI

hedged sentence

0.0480

closest p · 1.0× alpha

0.0480

boldest claim

The sentences

at the limit of significanceP = 0.048actually significant

5 a,c), p53 and hScrib levels in the MG132/m‐treated group were also significantly greater than those in MG132‐treated group, although the difference in p53 intensity between free MG132 and MG132/m was at the limit of significance ( P = 0.048).

also in 326 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.